Search clinical trials for: favezelimab/pembrolizumab
Total 2290 results
-
Sarcoma Alliance for Research through CollaborationMerck Sharp & Dohme LLCCompletedSoft Tissue Sarcoma | Bone SarcomaUnited States
-
Merck Sharp & Dohme LLCCompleted
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedMetastatic Breast CancerFrance, Austria, Belgium, Australia, Italy
-
University of ChicagoWithdrawnHead and Neck CancerUnited States
-
Glenmark Specialty S.A.RecruitingLymphoma | Advanced Solid TumorUnited States, India
-
ImmuneSensor Therapeutics Inc.RecruitingOligometastatic DiseaseUnited States
-
Duke UniversityMerck Sharp & Dohme LLCCompletedGastric Cancer | Esophagus CancerUnited States
-
Cytovation ASMerck Sharp & Dohme LLCActive, not recruitingAdvanced Breast Cancer | Advanced Melanoma | Advanced Head and Neck Squamous Cell CarcinomaUnited States, France, Italy, Spain, Netherlands
-
Zarour, Hassane, MDMerck Sharp & Dohme LLCActive, not recruiting
-
Guangzhou Institute of Respiratory DiseaseRecruitingNon-small Cell Lung Cancer Stage IIIB/IVChina
-
Medical University InnsbruckMerck Sharp & Dohme LLCRecruitingNon Small Cell Lung CancerAustria
-
Memorial Sloan Kettering Cancer CenterRecruitingLung Cancer | Metastatic Cancer | Bladder Cancer | Renal Cancer | Melanoma Cancer | Head/Neck CancersUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedLymphoma | Metastatic Melanoma | Metastatic Renal Cell Cancer | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage III Bladder Cancer | Stage IV Bladder Cancer | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | IPSS Risk Category Intermediate-1United States
-
National Cancer Institute (NCI)RecruitingExtensive Stage Lung Small Cell Carcinoma | Limited Stage Lung Small Cell Carcinoma | Platinum-Resistant Lung Small Cell Carcinoma | Platinum-Sensitive Lung Small Cell Carcinoma | Recurrent Lung Small Cell CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingSarcoma | Metastatic Renal Cell Carcinoma | Metastatic Melanoma | Recurrent Renal Cell Carcinoma | Recurrent Melanoma | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Metastatic Colorectal Carcinoma | Stage IV Colorectal Cancer AJCC v8 | Clinical Stage IV Cutaneous Melanoma... and other conditionsUnited States, Canada
-
Mamta ParikhNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMetastatic Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Refractory Urothelial CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory T-Cell Non-Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory Transformed... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the BrainUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Astex Pharmaceuticals...CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Chase Heaton, MDIncyte Corporation; OncoSec Medical IncorporatedTerminatedRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell Carcinoma | Unresectable Head and Neck Squamous Cell CarcinomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCActive, not recruitingRecurrent Bladder Carcinoma | Stage I Bladder Cancer | Stage 0a Bladder Urothelial Carcinoma | Stage 0is Bladder Urothelial CarcinomaUnited States
-
Saint Petersburg State University, RussiaRecruitingAnaplastic Thyroid CancerRussian Federation
-
Shanghai Zhongshan HospitalActive, not recruitingCarcinoma, HepatocellularChina
-
Repertoire Immune MedicinesMerck Sharp & Dohme LLCTerminated
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingProgressive Multifocal LeukoencephalopathyFrance
-
John DiazMerck Sharp & Dohme LLC; Florida Department of HealthActive, not recruitingCervical Cancer | Cervical CarcinomaUnited States
-
UNICANCERMerck Sharp & Dohme LLC; Fondation ARC; ERA-NETActive, not recruitingVulvar Cancer | Cervix Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Penile Cancer | Squamous Cell Lung CancerFrance
-
Merck Sharp & Dohme LLCEuropean Organisation for Research and Treatment of CancerActive, not recruiting
-
RenJi HospitalRecruitingLiver Transplant; Complications | Hepatocellular Carcinoma RecurrentChina
-
Baylor Research InstituteRecruiting
-
Vincerx Pharma, Inc.Active, not recruitingNeoplasmsUnited States, Chile, Spain
-
Peking University Cancer Hospital & InstituteNot yet recruitingMucosal Melanoma | Neoadjuvant TreatmentChina
-
Northwestern UniversityNational Cancer Institute (NCI)WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Breast Inflammatory CarcinomaUnited States
-
Oslo University HospitalSt. Olavs HospitalRecruiting
-
Gustave Roussy, Cancer Campus, Grand ParisMerck Sharp & Dohme LLCCompleted
-
Ezra CohenMerck Sharp & Dohme LLCActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedFollicular Lymphomas | CD19+ Diffuse Large B-cell Lymphomas | Mantle Cell LymphomasUnited States
-
Nina BhardwajTerminated
-
Shi YuankaiRecruitingHead and Neck Squamous Cell CarcinomaChina
-
EverNov Medicines (Zhuhai Hengqin) Co., LtdMedidata SolutionsRecruiting
-
Yonsei UniversityNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Cedars-Sinai Medical CenterCompletedBreast Cancer | Metastatic Triple NegativeUnited States
-
University of Alabama at BirminghamMerck Sharp & Dohme LLCTerminatedPenile Squamous Cell CarcinomaUnited States
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLC; National Institute for Health Research Biomedical...Active, not recruitingTriple Negative Breast CancerUnited Kingdom
-
Five Prime Therapeutics, Inc.CompletedBreast Cancer | Ovarian Cancer | Advanced Solid Tumors | Endometrial CancerUnited States, Korea, Republic of
-
Takayuki YoshinoSumitomo Pharma Co., Ltd.Terminated
-
Eli Lilly and CompanyTerminatedHepatocellular Carcinoma | Solid Tumor | Gastric Adenocarcinoma | Leiomyosarcoma | Head and Neck Squamous Cell Carcinoma | Cervical Carcinoma | Triple-negative Breast Cancer | Undifferentiated Pleomorphic Sarcoma | High Grade Serous Ovarian CarcinomaUnited States, Japan
-
Oslo University HospitalMerck Sharp & Dohme LLCTerminatedMalignant Peripheral Nerve Sheath Tumour (MPNST)Norway
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLCTerminatedPatients With Leptomeningeal DiseaseUnited States